Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 175 microgram - tablet - excipient ingredients: magnesium stearate; maize starch; colloidal anhydrous silica; purified talc; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 200 microgram - tablet - excipient ingredients: purified talc; colloidal anhydrous silica; magnesium stearate; maize starch; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 88 microgram - tablet - excipient ingredients: colloidal anhydrous silica; maize starch; magnesium stearate; purified talc; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 150 microgram - tablet - excipient ingredients: purified talc; maize starch; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 25 microgram - tablet - excipient ingredients: purified talc; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; pregelatinised maize starch - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; dextrin; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: magnesium stearate; dextrin; maize starch; lactose monohydrate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; dextrin; lactose monohydrate; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet, uncoated - excipient ingredients: dextrin; maize starch; magnesium stearate; lactose monohydrate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.05 mg - tablet, uncoated - excipient ingredients: dextrin; maize starch; lactose monohydrate; magnesium stearate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.